Mutant somatropin - JCR PharmaceuticalAlternative Names: Mutant growth hormone
Latest Information Update: 15 Aug 2002
At a glance
- Originator JCR Pharmaceuticals
- Class Hormones
- Mechanism of Action Somatotropin receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Acromegaly
Most Recent Events
- 18 Apr 1997 New profile
- 18 Apr 1997 Preclinical development for Acromegaly in Japan (Unknown route)